Owner Ortho-McNeil Pharmaceutical, Inc.

Inventors Lovenberg, Timothy; Liu, Changlu

Agent Shelston IP

Pub. Number AU-B-2001241713

PCT Pub. Number WO01/92485

Priority 60208260 31.05.00 US

Filing date 22 February 2001

Wipo publication date 11 December 2001

Acceptance publication date 2 February 2006

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

A61K 38/15 (2006.01) Medicinal preparations containing peptides - Depsipeptides

C07K 14/435 (2006.01) Peptides having more than 20 amino acids - from animals

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

C07K 14/71 (2006.01) Peptides having more than 20 amino acids

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 16/22 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

C12N 15/63 (2006.01) Mutation or genetic engineering - Introduction of foreign genetic material using vectors

C12N 15/64 (2006.01) Mutation or genetic engineering - General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/567 (2006.01) Investigating or analysing materials by specific methods not covered by groups - utilising isolate of tissue or organ as binding agent